diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance - In type 2 diabetes, cells in muscles, fat, and liver become resistant to insulin, reducing glucose uptake and causing hyperglycemia, as insulin is less effective at facilitating glucose entry into cells.

• Secondary mechanism: Beta-cell dysfunction - Over time, the pancreas' beta cells, which produce insulin, become impaired or exhausted, leading to insufficient insulin production relative to the body's needs, exacerbating high blood sugar levels.

• Key complication: Hyperglycemia - Persistent high blood sugar can lead to complications such as cardiovascular disease, neuropathy, nephropathy, and retinopathy, emphasizing the importance of managing blood glucose levels to prevent long-term damage.

Patient Profile

Demographics:

58-year-old female, retired school teacher

History:

• Key past medical history: Type 2 diabetes diagnosed 10 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased fatigue and occasional blurred vision

• Key symptoms: Numbness and tingling in feet, frequent urination, increased thirst

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 190 mg/dL

Section 1

New Diagnostic Results:

During a follow-up appointment, the patient's primary care physician ordered a series of tests to further evaluate her current symptoms and diabetes management. The results revealed a hemoglobin A1c level of 8.5%, indicating suboptimal long-term glucose control. In addition to the elevated A1c, the patient's microalbuminuria test returned positive, suggesting early signs of diabetic nephropathy. These findings are consistent with the patient's complaints of increased fatigue and blurred vision, as they can be manifestations of uncontrolled blood glucose levels and developing microvascular complications. The numbness and tingling in her feet are also indicative of peripheral neuropathy, a common complication in diabetic patients with prolonged hyperglycemia.

The physician also ordered a comprehensive metabolic panel, which showed a mild elevation in serum creatinine to 1.4 mg/dL, indicating decreased kidney function. Additionally, a fundoscopy was performed, revealing early signs of diabetic retinopathy, such as microaneurysms and cotton wool spots in the retina. These diagnostic results highlight the progression of the patient's diabetes complications and underscore the need for an urgent review of her current treatment regimen. The physician discussed the importance of tighter glycemic control and the potential need for medication adjustments or additions, such as initiating insulin therapy or incorporating an SGLT2 inhibitor to provide renal protection and improve cardiovascular outcomes.

Considering these findings, the healthcare team emphasized the necessity of a multidisciplinary approach, involving a diabetes educator for lifestyle modifications, a dietitian for nutritional counseling, and a nephrologist for managing early renal changes. The patient was counseled on the significance of regular monitoring of her blood glucose levels, blood pressure control, and adherence to her medication regimen to prevent further complications. As the team develops a comprehensive care plan, the patient is encouraged to actively participate in her healthcare management to improve her quality of life and prevent the progression of diabetes-related complications.

Section 2

Change in Patient Status:

A few weeks after the adjustments to her treatment plan, the patient returns for another follow-up appointment. During this visit, she reports some improvement in her energy levels but continues to experience episodes of blurred vision and persistent numbness in her feet. Despite her efforts to adhere to the recommended lifestyle changes and medication adjustments, her blood glucose logs exhibit significant fluctuations, with occasional readings exceeding 250 mg/dL. This inconsistent glycemic control raises concerns about her risk for further complications.

Upon examination, the patient’s vital signs reveal a blood pressure of 145/90 mmHg, slightly elevated from her previous visit, suggesting that her hypertension remains suboptimally managed. Her weight remains stable, indicating that there has been no significant change in her BMI; however, the physical examination notes diminished sensation in her lower extremities, consistent with peripheral neuropathy progression. The healthcare team decides to repeat some of the key laboratory tests to reassess her condition and guide further interventions.

The repeat hemoglobin A1c test now reads 8.2%, showing a slight improvement but still above the target goal. Serum creatinine remains at 1.4 mg/dL, indicating stable but impaired renal function. The team also conducts a lipid profile, revealing elevated LDL cholesterol at 130 mg/dL and triglycerides at 180 mg/dL, both factors that can exacerbate cardiovascular risks. These findings prompt a discussion about the potential need to intensify her antihypertensive therapy and consider the introduction of a statin to manage dyslipidemia. As the patient and her healthcare providers discuss these results, they emphasize the importance of ongoing monitoring and the potential benefits of further refining her treatment plan to address these persistent challenges and prevent additional complications.

Section 3

A month after her last follow-up, the patient returns to the clinic, reporting worsening symptoms. She describes experiencing more frequent episodes of blurred vision, particularly in the evenings, and has noticed an increased need to urinate overnight. Her feet have become more numb, and she occasionally feels a burning sensation. Despite maintaining her medication regimen and dietary adjustments, her home glucose monitoring indicates several readings above 300 mg/dL. This raises an alarm about potential exacerbation of her diabetes-related complications.

Upon examination, her vital signs show a blood pressure of 150/95 mmHg, indicating further elevation. Her heart rate is 88 beats per minute, and she exhibits mild tachycardia. A detailed neurological examination reveals a positive monofilament test in her feet, confirming significant peripheral neuropathy progression. A fundoscopic exam shows early signs of diabetic retinopathy, aligning with her recent visual disturbances. These findings suggest that her microvascular complications are advancing, likely due to persistent hyperglycemia and hypertension.

Given these developments, the healthcare team orders an additional set of diagnostic tests, including a urine microalbumin test, which returns positive, indicating early diabetic nephropathy. Her hemoglobin A1c has risen slightly to 8.5%, suggesting worsening glycemic control. The team discusses the potential need for insulin therapy to achieve better glucose regulation, alongside adjustments to her antihypertensive regimen to target her blood pressure more aggressively. The patient is advised on the importance of these changes to prevent further complications and is scheduled for a follow-up visit in two weeks to evaluate her response to the intensified treatment plan.

Section 4

Two weeks later, the patient returns for her follow-up appointment, and her response to the intensified treatment plan is assessed. Upon arrival, she reports feeling slightly more energetic and notes that her episodes of blurred vision have decreased in frequency. However, she continues to experience nocturnal polyuria and persistent numbness in her feet. Her home glucose monitoring now shows a reduction in hyperglycemic episodes, with most readings falling between 180-220 mg/dL, indicating some improvement, though not optimal control.

During the clinical examination, her blood pressure has decreased to 140/90 mmHg, reflecting a modest response to the adjusted antihypertensive regimen. Her heart rate remains stable at 85 beats per minute. A repeat neurological assessment shows no significant change in peripheral neuropathy. Her fundoscopic exam remains unchanged, suggesting that her diabetic retinopathy has not progressed further. Lab results reveal a slight improvement in her hemoglobin A1c to 8.2%, indicating better glucose management, but still above target levels.

The healthcare team reviews these findings and considers the current interventions. They decide to continue the insulin therapy with a slight increase in dosage to further improve glycemic control. Additionally, they emphasize the importance of daily foot care and routine eye examinations to monitor for potential complications. The patient is educated on recognizing early signs of hypoglycemia as her body adjusts to insulin. A follow-up appointment is scheduled in four weeks to evaluate her long-term response and to make further adjustments if necessary. This ongoing monitoring aims to stabilize her condition and prevent the progression of her diabetes-related complications.

Section 5

Four weeks later, the patient returns for her follow-up appointment. She reports that her energy levels have improved, and she feels more motivated to engage in physical activity, although she is still cautious due to the persistent numbness in her feet. Her nocturnal polyuria has decreased in frequency, and she has not experienced any episodes of hypoglycemia, suggesting that the insulin dose adjustment has been beneficial. However, she mentions a new development of occasional tingling sensations in her hands, which is a potential sign of peripheral neuropathy progression.

During the physical examination, her blood pressure has improved further to 135/85 mmHg, and her heart rate remains stable at 82 beats per minute. Her weight has decreased slightly, which is a positive sign indicating adherence to lifestyle modifications. Her neurological assessment reveals no significant worsening of her lower extremity neuropathy, but there is a new finding of decreased sensation in the fingers of both hands. A follow-up fundoscopic exam shows stable diabetic retinopathy with no new hemorrhages or exudates.

The lab results show a further reduction in her hemoglobin A1c to 7.9%, which is encouraging but still above the target of less than 7%. Her fasting glucose levels are now consistently between 150-180 mg/dL, indicating gradual improvement. However, the new onset of upper extremity neuropathy prompts the healthcare team to consider additional interventions. They decide to consult a neurologist for a more comprehensive evaluation of her neuropathy and to explore possible adjustments to her medication regimen. The patient is counseled on the importance of continued glucose monitoring and adherence to her treatment plan, emphasizing the need to address both the glycemic control and the neuropathic symptoms to prevent further complications. A follow-up appointment is scheduled in six weeks to reassess and make necessary adjustments based on the neurologist's recommendations and the patient's overall response to the current treatment plan.